These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 32535124)

  • 1. Acute Kidney Function Declines in the Context of Decongestion in Acute Decompensated Heart Failure.
    McCallum W; Tighiouart H; Testani JM; Griffin M; Konstam MA; Udelson JE; Sarnak MJ
    JACC Heart Fail; 2020 Jul; 8(7):537-547. PubMed ID: 32535124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rates of Reversal of Volume Overload in Hospitalized Acute Heart Failure: Association With Long-term Kidney Function.
    McCallum W; Tighiouart H; Testani JM; Griffin M; Konstam MA; Udelson JE; Sarnak MJ
    Am J Kidney Dis; 2022 Jul; 80(1):65-78. PubMed ID: 34843844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relation of Kidney Function Decline and NT-proBNP With Risk of Mortality and Readmission in Acute Decompensated Heart Failure.
    McCallum W; Tighiouart H; Kiernan MS; Huggins GS; Sarnak MJ
    Am J Med; 2020 Jan; 133(1):115-122.e2. PubMed ID: 31247182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rates of In-Hospital Decongestion and Association with Mortality and Cardiovascular Outcomes Among Patients Admitted for Acute Heart Failure.
    McCallum W; Tighiouart H; Testani JM; Griffin M; Konstam MA; Udelson JE; Sarnak MJ
    Am J Med; 2022 Sep; 135(9):e337-e352. PubMed ID: 35472391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Markers of decongestion, dyspnea relief, and clinical outcomes among patients hospitalized with acute heart failure.
    Kociol RD; McNulty SE; Hernandez AF; Lee KL; Redfield MM; Tracy RP; Braunwald E; O'Connor CM; Felker GM;
    Circ Heart Fail; 2013 Mar; 6(2):240-5. PubMed ID: 23250981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Competing Risk of Cardiac Status and Renal Function During Hospitalization for Acute Decompensated Heart Failure.
    Salah K; Kok WE; Eurlings LW; Bettencourt P; Pimenta JM; Metra M; Verdiani V; Tijssen JG; Pinto YM
    JACC Heart Fail; 2015 Oct; 3(10):751-61. PubMed ID: 26449995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Change in the NT-proBNP/Mature BNP Molar Ratio Precedes Worsening Renal Function in Patients With Acute Heart Failure: A Novel Predictor Candidate for Cardiorenal Syndrome.
    Takahama H; Nishikimi T; Takashio S; Hayashi T; Nagai-Okatani C; Asada T; Fujiwara A; Nakagawa Y; Amano M; Hamatani Y; Okada A; Amaki M; Hasegawa T; Kanzaki H; Nishimura K; Yasuda S; Kangawa K; Anzai T; Minamino N; Izumi C
    J Am Heart Assoc; 2019 Sep; 8(17):e011468. PubMed ID: 31441355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early glomerular filtration rates changes and risk of mortality in acute heart failure. The modifying role of admission renal function and decongestion.
    Lorenzo M; Núñez G; Fuertes-Kenneally L; de la Espriella R; Villar S; Miró O; Llorens P; Santas E; Miñana G; Bodí V; Sanchis J; Carratalá A; Bayés-Genís A; Núñez J
    Eur J Intern Med; 2023 Sep; 115():96-103. PubMed ID: 37316355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Empagliflozin as an Add-On Therapy on Decongestion and Renal Function in Patients With Diabetes Hospitalized for Acute Decompensated Heart Failure: A Prospective Randomized Controlled Study.
    Tamaki S; Yamada T; Watanabe T; Morita T; Furukawa Y; Kawasaki M; Kikuchi A; Kawai T; Seo M; Abe M; Nakamura J; Yamamoto K; Kayama K; Kawahira M; Tanabe K; Fujikawa K; Hata M; Fujita Y; Umayahara Y; Taniuchi S; Sanada S; Shintani A; Fukunami M
    Circ Heart Fail; 2021 Mar; 14(3):e007048. PubMed ID: 33663235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Timing of hemoconcentration during treatment of acute decompensated heart failure and subsequent survival: importance of sustained decongestion.
    Testani JM; Brisco MA; Chen J; McCauley BD; Parikh CR; Tang WH
    J Am Coll Cardiol; 2013 Aug; 62(6):516-24. PubMed ID: 23747773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B-type natriuretic peptide trend predicts clinical significance of worsening renal function in acute heart failure.
    Wettersten N; Horiuchi Y; van Veldhuisen DJ; Mueller C; Filippatos G; Nowak R; Hogan C; Kontos MC; Cannon CM; Müeller GA; Birkhahn R; Taub P; Vilke GM; Barnett O; McDonald K; Mahon N; Nuñez J; Briguori C; Passino C; Murray PT; Maisel A
    Eur J Heart Fail; 2019 Dec; 21(12):1553-1560. PubMed ID: 31769140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal dysfunction and accuracy of N-terminal pro-B-type natriuretic peptide in predicting mortality for hospitalized patients with heart failure.
    Scrutinio D; Mastropasqua F; Guida P; Ammirati E; Ricci V; Raimondo R; Frigerio M; Lagioia R; Oliva F
    Circ J; 2014; 78(10):2439-46. PubMed ID: 25168191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of BNP and NT-proBNP in Patients With Heart Failure and Reduced Ejection Fraction.
    Rørth R; Jhund PS; Yilmaz MB; Kristensen SL; Welsh P; Desai AS; Køber L; Prescott MF; Rouleau JL; Solomon SD; Swedberg K; Zile MR; Packer M; McMurray JJV
    Circ Heart Fail; 2020 Feb; 13(2):e006541. PubMed ID: 32065760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haemoconcentration, renal function, and post-discharge outcomes among patients hospitalized for heart failure with reduced ejection fraction: insights from the EVEREST trial.
    Greene SJ; Gheorghiade M; Vaduganathan M; Ambrosy AP; Mentz RJ; Subacius H; Maggioni AP; Nodari S; Konstam MA; Butler J; Filippatos G;
    Eur J Heart Fail; 2013 Dec; 15(12):1401-11. PubMed ID: 23845795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations of N-terminal pro-B-type natriuretic peptide with kidney function decline in persons without clinical heart failure in the Heart and Soul Study.
    Park M; Vittinghoff E; Shlipak MG; Mishra R; Whooley M; Bansal N
    Am Heart J; 2014 Dec; 168(6):931-9.e2. PubMed ID: 25458658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cystatin C-based CKD-EPI equations and N-terminal pro-B-type natriuretic peptide for predicting outcomes in acutely decompensated heart failure.
    Flores-Blanco PJ; Manzano-Fernández S; Pérez-Calvo JI; Pastor-Pérez FJ; Ruiz-Ruiz FJ; Carrasco-Sánchez FJ; Morales-Rull JL; Pascual-Figal D; Galisteo-Almeda L; Januzzi JL
    Clin Cardiol; 2015 Feb; 38(2):106-13. PubMed ID: 25663560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combining the use of amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the prognosis of hospitalized heart failure patients.
    Wang Y; Zhang R; Huang Y; Zhai M; Zhou Q; An T; Huang Y; Zhao X; Tian P; Zhang Y; Zhang J
    Clin Chim Acta; 2019 Apr; 491():8-14. PubMed ID: 30594544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-Terminal Pro-B-Type Natriuretic Peptide and Clinical Outcomes: Vericiguat Heart Failure With Reduced Ejection Fraction Study.
    Ezekowitz JA; O'Connor CM; Troughton RW; Alemayehu WG; Westerhout CM; Voors AA; Butler J; Lam CSP; Ponikowski P; Emdin M; Patel MJ; Pieske B; Roessig L; Hernandez AF; Armstrong PW
    JACC Heart Fail; 2020 Nov; 8(11):931-939. PubMed ID: 33039447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Impact of BNP Variations in Patients Admitted for Acute Decompensated Heart Failure with In-Hospital Worsening Renal Function.
    Stolfo D; Stenner E; Merlo M; Porto AG; Moras C; Barbati G; Aleksova A; Buiatti A; Sinagra G
    Heart Lung Circ; 2017 Mar; 26(3):226-234. PubMed ID: 27523462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal ultrasonography predicts worsening renal function in patients with heart failure under tolvaptan administration.
    Tanaka N; Furukawa Y; Maeda T; Ishihara H; Dan K; Teramura M; Ichihashi K; Takase T; Takahashi Y; Tsuzura D; Shinoda A; Fujii M; Okada H; Itabashi F; Teramoto T
    ESC Heart Fail; 2024 Aug; 11(4):1911-1918. PubMed ID: 38468548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.